C52 — Malignant neoplasm of vagina
Is C52 billable?
Yes — C52 is billable for FY2027. C52 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C52 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C52 at a glance
| Code | C52 |
|---|---|
| Description | Malignant neoplasm of vagina |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C52 group to?
C52 sits in MDC 13 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 731Uterine and Adnexa Procedures for Malignancy with MCCsurgical
- 732Uterine and Adnexa Procedures for Malignancy with CCsurgical
- 733Uterine and Adnexa Procedures for Malignancy without CC/MCCsurgical
Excludes1 — never code together
The conditions below can never be reported together with C52 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- carcinoma in situ of vagina (D07.2)
How long has C52 existed?
C52 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
Which codes are confused with C52?
ICD-10-CM declares these codes mutually exclusive with C52 — exactly one of each pair can be correct for a given encounter.